Ftse Mib
34.605,55
-0,63%
DAX
18.712,27
-0,29%
S&P 500
5.314,92
0,13%
NASDAQ
16.805,97
0,07%
Bitcoin
70.294,96
-1,60%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sierra Oncology Inc (SRRA) Sierra Oncology Inc (SRRA) Notizie

SRRA

Sierra Oncology (SRRA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRRA
DataOraFonteTitoloSimboloCompagnia
14/02/202321:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SRRASierra Oncology Inc
18/07/202222:05GlobeNewswire Inc.Codexis Announces CEO Transition Effective August 9, 2022NASDAQ:SRRASierra Oncology Inc
11/07/202222:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SRRASierra Oncology Inc
11/07/202222:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:SRRASierra Oncology Inc
01/07/202223:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SRRASierra Oncology Inc
01/07/202222:19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SRRASierra Oncology Inc
01/07/202222:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SRRASierra Oncology Inc
01/07/202222:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SRRASierra Oncology Inc
01/07/202215:38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SRRASierra Oncology Inc
17/06/202213:00Business WireSierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug AdministrationNASDAQ:SRRASierra Oncology Inc
26/05/202223:00Business WireMomelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual MeetingNASDAQ:SRRASierra Oncology Inc
16/05/202222:16Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SRRASierra Oncology Inc
12/05/202216:00Business WireSierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual MeetingNASDAQ:SRRASierra Oncology Inc
06/05/202213:00Business WireSierra Oncology Reports First Quarter 2022 ResultsNASDAQ:SRRASierra Oncology Inc
05/05/202222:05Business WireSierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:SRRASierra Oncology Inc
02/05/202222:57Business WireSIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRANASDAQ:SRRASierra Oncology Inc
22/04/202220:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SRRASierra Oncology Inc
14/04/202213:26TipRanksWhy Did Sierra Oncology Skyrocket on Wednesday?NASDAQ:SRRASierra Oncology Inc
13/04/202223:17Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:SRRASierra Oncology Inc
13/04/202222:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SRRASierra Oncology Inc
13/04/202209:24Dow Jones NewsGlaxoSmithKline to Acquire Sierra Oncology for $1.9 Billion -- UpdateNASDAQ:SRRASierra Oncology Inc
13/04/202208:57Dow Jones NewsGlaxoSmithKline to Acquire Sierra Oncology for $1.9 BillionNASDAQ:SRRASierra Oncology Inc
13/04/202208:05Business WireGSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bnNASDAQ:SRRASierra Oncology Inc
14/03/202216:05TipRanksAnalysts Offer Insights on Healthcare Companies: Sierra Oncology (SRRA) and DarioHealth (DRIO)NASDAQ:SRRASierra Oncology Inc
11/03/202213:00Business WireSierra Oncology to Participate in the Oppenheimer 32nd Annual Healthcare ConferenceNASDAQ:SRRASierra Oncology Inc
10/03/202217:05TipRanksAnalysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV) and Sierra Oncology (SRRA)NASDAQ:SRRASierra Oncology Inc
10/03/202213:46Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SRRASierra Oncology Inc
10/03/202213:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SRRASierra Oncology Inc
10/03/202213:00Business WireSierra Oncology Reports 2021 Year End ResultsNASDAQ:SRRASierra Oncology Inc
03/02/202222:05Business WireSierra Oncology Announces Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SRRASierra Oncology Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SRRA

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
G
Generali
BIT
ENI
Eni
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
TITR
Telecom Italia
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network